Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Qiagen Gains SFDA Approval for HPV Test Aimed at Rural Areas

publication date: Nov 29, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Qiagen, the Dutch diagnostics company, has been granted SFDA approval for its careHPV Test. According to the company, the test is the first molecular diagnostic to screen for high-risk human papillomavirus (HPV) that is designed for resource-poor clinical settings – settings that lack electricity, water or a modern lab. The test can provide results during the patient’s visit. Qiagen will manufacture the test in its Shenzhen plant. More details....

Stock Symbol: (NSDQ: QGEN)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...